Russia in the office of the profile, open-based endocrinological institutions. Currently, department is a subdivision of the Institute of Reproductive Endocrinology, which allows for close contact with a gynecologist who was essential in addressing not only reproductive but also sexual health in the family. Since 2007, the clinic conducted various types of surgical interventions on the urinary organs, and therefore formed by two lines of scientific and practical activities: conservative and surgical andrology uroandrologii.
The main directions of scientific and practical activities of the Andrology and Urology:
* Correction copulative and reproductive health of the family.
* Diagnosis and treatment of complex disorders of sexual function in man.
* Diagnosis and comprehensive treatment of male infertility.
* Diagnosis and treatment of diseases of the prostate, urethra, external genitalia:
o Chronic prostatitis.
o Chronic pelvic pain.
o Benign prostatic hyperplasia (treatment of prostate adenoma).
o Sexually transmitted infections.
o A survey before the planned conception.
* Surgical correction of congenital and acquired anomalies of genital organs, deformities and hypoplasia.
* Reconstruction of the penis and urethra.
* Correction strictures and obliteration of the urethra, hypospadias, epispadia, treatment of stricture of the urethra.
* Conservative and surgical treatment of Peyronie's disease.
* Hormonal and surgical methods for correction of sex.
* Diagnosis and treatment of delayed sexual and physical development of boys.
* Diagnosis and treatment of congenital malformations of the external genitalia.
* Correction of age disorders in men:
o Treatment of androgen deficiency of aging.
o sexual disorders.
o Correction of obesity, osteoporosis, gynecomastia in men.
o Extension of the creative and physical activity.
* Diagnosis and treatment of urination, urinary incontinence in men and women.
* Inflammatory diseases of the urogenital system of men and women (cystitis, pyelonephritis).
Conservative uroandrologiya
Conservative uroandrologiya - Section of Urology, dedicated to the study and non-surgical treatment of diseases specific to the male body. The main diseases falling under the authority of this section are:
* Inflammatory diseases of the genitourinary system - pyelonephritis, cystitis, prostatitis, urethritis (including sexually transmitted infections), orchitis, epididymitis, balanoposthitis.
* Noninflammatory diseases of the genitourinary system - benign prostatic hyperplasia (adenoma), a syndrome of chronic pelvic pain, urination disorders of different nature.
* Sexual problems (violation of libido, ejaculation, orgasm, erectile dysfunction) and reproductive health (male infertility).
* Other problems associated with the peculiarities of man's body - asthenia (abnormal fatigue), age androgenodefitsit, poor quality of life for men of any age, etc.
Genital Surgery
Genital surgery - is a separate line in the modern plastic-reconstructive surgery and urology, implying a holding of various surgical interventions on the genitals.
In the sphere of interest genital surgery get surgery performed on the penis, scrotum, testes and the urethra (the urethra). Priority and the most rapidly developing area of the operations on the penis and urethra.
Erectile dysfunction
Erectile dysfunction - the inability of men to achieve and / or maintain an erection sufficient for introducing the penis into the vagina and the commission of a satisfactory sexual intercourse.
Such common sexual disorders, as decreased sex drive, rapid ejaculation, orgasm violation - is not erectile dysfunction.
* Erectile dysfunction is suffering from more than 50% of men older than 40 years.
* Erectile dysfunction - is a disease for more than 150 million men worldwide, including approximately 20 million Europeans and 30 million Americans.
* Every 10 men over 21 suffer from erectile dysfunction.
* Full impotence occurs in 5% of men aged 40 years and 15% at age 70.
* 35% of men with erectile dysfunction are severely erectile dysfunction.
* A man should not tolerate the violation or lack of erection.
Treatment of urinary incontinence
Urinary incontinence significantly affects the household, family and professional spheres of life of the patient, delivers constant discomfort, but because patients need to be timely treatment. Urinary incontinence can cause irritation of the skin of perineum, urinary tract infections and emotional discomfort. Urinary incontinence leads to the development of other diseases of internal organs.
viagra from canada
cheap viagra pills
viagra order
viagra super active
viagra 100mg
low cost viagra
generic viagra india
viagra generico
buy viagra on line
viagra uk
viagra no prescription
purchase viagra online
canadian pharmacy viagra
buy cheap viagra online
buy viagra without prescription
viagra dosage
Saturday, October 31, 2009
Thursday, October 22, 2009
Levitra Solution Medications US
Levitra (vardenafil) - a new drug to address erectile dysfunction, so-called "Packaging with flame.
Violation of erectile function ( "weakness" of the penis) identify the millions of men around the world, which is very important and determines the popularity and importance of drugs for its restoration. According to WHO, the prevalence of erectile dysfunction in the world - 52% among men older than 40 years. In Russia, a potential group of at least 13 million people. According to various studies, is currently receiving treatment about 200000 - 500000 people. Every year the number of men suffering from erectile function disorder is increasing. The problem is that men do not pay enough attention to their sexual health. Entering the market of drugs for the treatment of erectile dysfunction allowed us to draw attention to the problem and increase the number of men who are looking for a solution.
The global pharmaceutical market represented three original drug used for erectile dysfunction: Viagra manufactured by Pfizer (long known to consumers in the United States and Europe), Cialis manufactured by Eli Lilly (appeared on the market at the end of 2003) and Levitra (vardenafil) - a new drug made by German pharmaceutical Bayer, the promoting, together with the company GlaxoSmithKline.
Cialis and Levitra are one principle of Viagra and have more similarities with it than differences - have a peripheral effect on erections. All three drugs have similar mechanism of action, which is caused by the blocking of specific phosphodiesterase type 5 - PDE5 (responsible for the breakdown of cGMP), which contains the largest number in a cavernous (cavernous), the body of the penis. As a result of blocking this enzyme accumulation of cyclic guanosine monophosphate, which leads to relaxation of smooth muscle in the cavernous body of penis and its associated arterioles. The consequence of this is the blood flow to the tissues of the penis that causes erections.
Manufacturers Cialis sees his advantage in that it operates longer (up to 36 hours) compared with Viagra (4 - 5 hours). And according to the head of the Medical Department, representing the interests of Russia Bayer, Levitra begins to act much faster than competing drugs, about 15 minutes after administration, ie is the most bysrodeystvuyuschim tool.
Violation of erectile function ( "weakness" of the penis) identify the millions of men around the world, which is very important and determines the popularity and importance of drugs for its restoration. According to WHO, the prevalence of erectile dysfunction in the world - 52% among men older than 40 years. In Russia, a potential group of at least 13 million people. According to various studies, is currently receiving treatment about 200000 - 500000 people. Every year the number of men suffering from erectile function disorder is increasing. The problem is that men do not pay enough attention to their sexual health. Entering the market of drugs for the treatment of erectile dysfunction allowed us to draw attention to the problem and increase the number of men who are looking for a solution.
The global pharmaceutical market represented three original drug used for erectile dysfunction: Viagra manufactured by Pfizer (long known to consumers in the United States and Europe), Cialis manufactured by Eli Lilly (appeared on the market at the end of 2003) and Levitra (vardenafil) - a new drug made by German pharmaceutical Bayer, the promoting, together with the company GlaxoSmithKline.
Cialis and Levitra are one principle of Viagra and have more similarities with it than differences - have a peripheral effect on erections. All three drugs have similar mechanism of action, which is caused by the blocking of specific phosphodiesterase type 5 - PDE5 (responsible for the breakdown of cGMP), which contains the largest number in a cavernous (cavernous), the body of the penis. As a result of blocking this enzyme accumulation of cyclic guanosine monophosphate, which leads to relaxation of smooth muscle in the cavernous body of penis and its associated arterioles. The consequence of this is the blood flow to the tissues of the penis that causes erections.
Manufacturers Cialis sees his advantage in that it operates longer (up to 36 hours) compared with Viagra (4 - 5 hours). And according to the head of the Medical Department, representing the interests of Russia Bayer, Levitra begins to act much faster than competing drugs, about 15 minutes after administration, ie is the most bysrodeystvuyuschim tool.
Subscribe to:
Posts (Atom)